Eyal C. Attar
Overview
Eyal C. Attar received an average of $1M in total compensation, including $380K in salary, at Aprea Therapeutics from 2019 to 2022.
Source: SEC filings on July 11, 2023, June 10, 2022, April 28, 2021, and April 29, 2020.
Related executives
We found five more executives who work or worked at Aprea Therapeutics.
News
Aprea Therapeutics CEO Christian Schade's 2022 pay falls 58% to $1.4M
July 11, 2023
Aprea Therapeutics CEO Christian Schade's 2021 pay slips 17% to $3.2M
June 10, 2022
Aprea Therapeutics CEO Christian Schade's 2020 pay rises 6% to $3.9M
April 28, 2021
Aprea Therapeutics CEO Christian Schade's 2019 pay jumps 520% to $3.7M
April 29, 2020